Advertisement

Rheumatology International

, Volume 6, Issue 2, pp 69–77 | Cite as

Differential diagnosis of fever in systemic lupus erythematosus using discriminant analysis

  • T. Inoue
  • T. Takeda
  • S. Koda
  • N. Negoro
  • M. Okamura
  • K. Amatsu
  • M. Kohno
  • T. Horiguchi
  • Y. Kanayama
Originals

Summary

In an attempt to find a reliable method to assess fever in patients with systemic lupus erythematosus (SLE), a multifactorial analysis was applied to the routine laboratory examinations, including white blood cell count (WBC) and serum globulin fraction concentrations. During 74 febrile episodes, 49 SLE patients showed increased disease activity and the remaining 25 febrile episodes were due to intercurrent infection. The two different groups of fever episodes were clearly separated by a principal component analysis using five variables from the routine laboratory tests, including WBC, serum alpha-1, alpha-2, beta, and gamma globulins. Discriminant analysis showed that 95% of 74 febrile episodes could be correctly classified as to the cause of fever when a combination of WBC and alpha-2 globulin level was used as variables. A simple discriminant formula which we calculated was considered to be of practical use for the differentiation of the two clinical entities.

Key words

Systemic lupus erythematosus Fever Serum globulin fractions Discriminant analysis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dubois EL, Tuffanelli DL (1964) Clinical manifestations of systemic lupus erythematosus: computer analysis of 520 cases. JAMA 190:104–111Google Scholar
  2. 2.
    Estes D, Christian CL (1971) The natural history of systemic lupus erythematosus. Medicine 50:85–95Google Scholar
  3. 3.
    Stahl NI, Klippel JH, Decker JL (1979) Fever in systemic lupus erythematosus. Am J Med 67:935–940Google Scholar
  4. 4.
    Becker GJ, Waldburger M, Hughes GRV, Pepys MB (1980) Value of C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. Ann Rheum Dis 39:50–52Google Scholar
  5. 5.
    Morrow WJ, Isenberg DA, Todd-Pokropek A, Parry HF, Snaith ML (1982) Useful laboratory measurements in the managements of systemic lupus erythematosus. Q J Med NS 51:125–128Google Scholar
  6. 6.
    Hill AGS (1951) C-reactive protein in the chronic rheumatic disease. Lancet II:807–811Google Scholar
  7. 7.
    Honig S, Gorevic P, Weissmann G (1977) C-reactive protein in systemic lupus erythematosus. Arthritis Rheum 20:1065–1070Google Scholar
  8. 8.
    Zein N, Ganuza C, Kushner I (1979) Significance of serum C-reactive protein elevation in patients with systemic lupus erythematosus. Arthritis Rheum 22:7–12Google Scholar
  9. 9.
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Green Schaller J, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277Google Scholar
  10. 10.
    Inoue T, Kanayama Y, Katoh N, Ohe A, Amatsu K, Okamura M, Horiguchi T (1981) Significance of C-reactive protein elevation in the pretreatment stage of systemic lupus erythematosus. Scand J Rheumatol 10:222–224Google Scholar
  11. 11.
    Isenberg DA, Shoenfeld Y, Schwartz RS (1984) Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus. Arthritis Rheum 27:132–138Google Scholar
  12. 12.
    Anderson HC, McCarty M (1950) Determination of CRP in the blood as a measure of the activity of the disease process in acute rheumatic fever. Am J Med 8:445–455Google Scholar
  13. 13.
    Fischl MA, Pitchenik A, Gardner LB (1981) An index predicting relapse and need for hospitalization in patients with acute bronchial asthma. N Engl J Med 305:783–789Google Scholar
  14. 14.
    Pollak VE, Mandema E, Doig AB, Moore M, Kark RM (1961) Observations on electrophoresis of serum proteins from healthy North American Caucasian and Negro subjects and from patients with systemic lupus erythematosus. J Lab Clin Med 58:353–365Google Scholar
  15. 15.
    Ogryzlo MA, Maclachlan M, Dauphinee JA, Fletcher AA (1959) The serum proteins in health and disease. Am J Med 27:596–616Google Scholar
  16. 16.
    Agostoni A, Vergani C, Stabilini R, Marasini B, Arcidiacono R, Sbaffi A, Binaghi PC (1970) Immunochemical quantitation of acute phase reactive proteins in myocardial infarction. Am Heart J 80:313–318Google Scholar
  17. 17.
    Laurell C-B (1976) Determination and interpretation of plasma proteins. Aust Fam Physician 5:36–41Google Scholar
  18. 18.
    Rees EG, Wilkinson M (1959) Serum proteins in systemic lupus erythematosus. Br Med J No 5155:795–798Google Scholar
  19. 19.
    Owen JA, de Gruchy GC, Smith H (1960) Serum haptoglobins in hemolytic states. J Clin Pathol 13:478–482Google Scholar
  20. 20.
    Anastassea-Vlachou C, Kattamis C, Lagos P, Konstantoulakis M, Matsaniotis N (1973) Haptoglobin and a 2-macroglobulin levels in children with rheumatoid arthritis. Clin Chim Acta 44:259–262Google Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • T. Inoue
    • 1
  • T. Takeda
    • 1
  • S. Koda
    • 1
  • N. Negoro
    • 1
  • M. Okamura
    • 1
  • K. Amatsu
    • 1
  • M. Kohno
    • 1
  • T. Horiguchi
    • 1
  • Y. Kanayama
    • 1
  1. 1.The First Department of Internal MedicineOsaka City University Medical SchoolOsakaJapan

Personalised recommendations